APA (7th ed.) Citation

Papageorgiou, C., Zagouri, F., Dimopoulos, M., Manios, E., Kafouris, P., Tousoulis, D., . . . Toutouzas, K. (2020). Vascular inflammation and cardiovascular burden in metastatic breast cancer female patients receiving hormonal treatment and CDK 4/6 inhibitors or everolimus. European heart journal, 41(Supplement_2), . https://doi.org/10.1093/ehjci/ehaa946.3270

Chicago Style (17th ed.) Citation

Papageorgiou, C., F. Zagouri, M. Dimopoulos, E. Manios, P. Kafouris, D. Tousoulis, C. Anagnostopoulos, and K. Toutouzas. "Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus." European Heart Journal 41, no. Supplement_2 (2020). https://doi.org/10.1093/ehjci/ehaa946.3270.

MLA (9th ed.) Citation

Papageorgiou, C., et al. "Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus." European Heart Journal, vol. 41, no. Supplement_2, 2020, https://doi.org/10.1093/ehjci/ehaa946.3270.